BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15269984)

  • 1. [Expression of sialylated carbohydrate antigens and nm23-H1 gene in prognosis of breast cancer].
    Ding KF; Wu JM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):326-30, 339. PubMed ID: 15269984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
    Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
    Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of vascular endothelial growth factor and nm23-H1 gene and their relation to the prognosis of breast cancer in young women].
    Huang ZH; Su GQ; Mao QG; Wang QZ; Li Z; Yu JL; Fan YF
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1398-401. PubMed ID: 15604068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.
    Sgouros J; Galani E; Gonos E; Moutsatsou P; Belechri M; Skarlos D; Dionyssiou-Asteriou A
    In Vivo; 2007; 21(3):519-22. PubMed ID: 17591363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
    Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
    Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma.
    Ura H; Denno R; Hirata K
    Jpn J Cancer Res; 1996 May; 87(5):512-7. PubMed ID: 8641989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
    J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
    Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
    Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma.
    Wang YF; Chow KC; Chang SY; Chiu JH; Tai SK; Li WY; Wang LS
    Br J Cancer; 2004 Jun; 90(11):2186-93. PubMed ID: 15150613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer.
    Hsu NY; Chen CY; Hsu CP; Lin TY; Chou MC; Chiou SH; Chow KC
    Oncol Rep; 2007 Jul; 18(1):81-5. PubMed ID: 17549350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].
    Huang Y; Cai S; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):718-21. PubMed ID: 9772433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
    Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
    Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of nm23-H1, Fas and FasL in colorectal carcinoma tissues].
    Lin MH; Yao YH; Yu JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):503-5. PubMed ID: 16078572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.